APA

Melaiu O., Mina M., Chierici M., Boldrini R., Jurman G., Romania P., D'Alicandro V., Benedetti M. C., Castellano A., Liu T., Furlanello C., Locatelli F. & Fruci D. (20180619). PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Melaiu Ombretta, Mina Marco, Chierici Marco, Boldrini Renata, Jurman Giuseppe, Romania Paolo, D'Alicandro Valerio, Benedetti Maria C, Castellano Aurora, Liu Tao, Furlanello Cesare, Locatelli Franco and Fruci Doriana. 20180619. PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Melaiu O., Mina M., Chierici M., Boldrini R., Jurman G., Romania P., D'Alicandro V., Benedetti M. C., Castellano A., Liu T., Furlanello C., Locatelli F. and Fruci D. (20180619). PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Melaiu Ombretta, Mina Marco, Chierici Marco, Boldrini Renata, Jurman Giuseppe, Romania Paolo, D'Alicandro Valerio, Benedetti Maria C, Castellano Aurora, Liu Tao, Furlanello Cesare, Locatelli Franco and Fruci Doriana. PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20180619.